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Abstract
Pulmonary sclerosing hemangiomas (PSH) of the lung are uncommon tumors and may present cytological atypia
with unusual manifestations. The development of PSH combined with other different tumors in lung is extremely
rare. We report a case of coexistence of PSH and primary adenocarcinoma in a young female occurring in the
same pulmonary nodular mass of right lower lobe. The solitary mass of lung was well-circumscribed on chest
computed tomography (CT) and gross examination. Histologically, the mass contained two separated portions and
displayed typically histological features of PSH and acinar adenocarcinoma, respectively. In PSH portion, the tumor
was composed of sheets of round cells with scattered surface cuboidal cells forming small tubules. Both round and
surface cells were diffusely positive for epithelial membrane antigen (EMA) and thyroid transcription factor-1
(TTF-1), but lack immunoreactivity for pancytokeratin in round cells. In adenocarcinoma portion, the tumor cells
formed irregular-shaped glands with cytologically malignant cells infiltrating in fibroblastic stroma, and no
TTF-1-positive round cells could be observed in this portion. Under the microscopy, there was no gradual transition
of these two portions observed in mass. A diagnosis of PSH combined with primary adenocarcinoma of lung was
made. There was no evidence of tumor recurrence during the period of postoperative 6-month follow-up. To our
knowledge, this is the first case of coexistence of PSH and adenocarcinoma in the same nodule of lung. In
addition, the biological behavior and histological differential diagnosis of this tumor were also discussed.
Background
Pulmonary sclerosing hemangioma (PSH) is an uncom-
mon tumor and is thought to be a benign neoplasm of
lung [1,2]. However, histogenesis and biological behavior
of this tumor has not yet been clarified adequately. His-
tologically, the characteristics of PSH have been well-
described as papillary, solid, sclerotic, or hemorrhagic
patterns. PSH comprises two well-accepted cell types:
eosinophilic cuboidal epithelial lining cells and round
cells with either eosinophilic or clear cytoplasm [2].
Although most PSH cases have a mixture of these four
histological patterns with two cell types, unusual mor-
phological presentations have been revealed in a few
cases, such as atypical adenomatous hyperplasia or ade-
nocarcinoma-like area within the PSH [3]. However, to
our knowledge, so far there is no report to describe a
coexistence of PSH and primary adenocarcinoma within
the same lobe of lung in English literatures. Herein we
report a young female with PSH combined with adeno-
carcinoma in the same nodule of right lower lobe. His-
topathological findings and imaging features, as well as
outcome and differential diagnosis are to be discussed.
Case presentation
A 22-year-old woman with a 4-month history of pulmon-
ary mass was admitted to our hospital for further exami-
nation and treatment. The pulmonary mass was first
detected on chest radiography when she underwent
annual body examination at a local hospital (Figure 1A).
For unknown reasons, the patient failed to receive
workup and management at that time. On admission in
our hospital, physical examination and routine laboratory
test was no positive finding. Sputum examination showed
no pathogenic organisms and malignant cells. Chest
computed tomography (CT) revealed a well-defined
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located in the right lower lobe of lung. Contrast-
enhanced CT was not performed. Neither enlarged
lymph node nor remarkable image finding was noted in
the surrounding lung parenchyma (Figure 1B). According
to the recommendation of CT examination, the patient
underwent fiberoptic bronchoscopy and transbronchial
biopsy, but there was no definitive diagnosis obtained by
histological examination. A preoperative presumed diag-
nosis was PSH and inflammatory pseudotumor of lung.
A partial segmentextomy of the right lower lobe was
performed, and macroscopical examination revealed a
gray-red solitary nodular mass, measuring 2.7 × 2.5 cm,
located in the lung parechyma. The mass was well-
circumscribed, but there was no fibrous capsule around
the mass (Figure 2).
Under the microscopical examination, part of nodular
mass, measuring approximately 1.2 cm in longest dia-
meter, demonstrated classical solid pattern of PSH with
varying proportions of surface cuboidal cells and pale
round cells. In this area, the mass was composed of
sheets of round cells with scattered surface cuboidal
cells forming small tubules (Figure 3A). The surface
cuboidal cells resembling type II alveolar cells demon-
strated vacuolated and foamy cytoplasm with focal mild
nuclear atypia. While the round cells were pale round
cells showed uniform, medium-size polygonal nuclei
with moderate amounts of pale, eosinophilic or clear
cytoplasm (Figure 3B). In some area, papillary pattern
with hyalinizing stalks was also obsreved, and the sur-
face cuboidal cells lined the papillae surface (Figure 3C).
Neither necrosis nor mitotic activity was found in PSH
area. Immunohistochemically, round cells were positive
to epithelial membrane antigen (EMA), thyroid tran-
scription factor-1 (TTF-1), Estrogen receptor (ER), pro-
gesterone receptor (PR), and focally weak positive for
synaptophysin (Syn), but negative for pancytokeractin
(AE1/AE3). Surface cells were strongly positive for AE1/
AE3, EMA and TTF-1, but negative for ER, PR, Syn and
carcinoembryonic antigen (CEA) (Figure 3D-F). Interest-
ingly, however, acinar adenocarcinoma could be observed
in other area of the same nodular mass. In this area, mea-
suring approximately 1.0 cm in longest diameter, the
tumor cells formed irregular-shaped glands with cytologi-
cally malignant cells exhibiting hyperchromatic nuclei in a
fibroblastic stroma (Figure 4A). There was no round cells
found to distribute in the interstitial portion of gland
structures (Figure 4B). The field of PSH and acinar adeno-
carcinoma was separated in the mass, and there was no
gradual transition of these two parts observed in mass.
Immunohistochemically, tumor cells of adenocarcinoma
were positive for AE1/AE3, EMA, TTF-1 and CEA, but
negative for ER, PR, and Syn (Figure 4C-E). In addition,
no TTF-1-positive stromal cells could be observed in
Figure 1 Preoperative chest radiology of lesion. (a) Chest X-ray revealed solitary pulmonary mass in right lower lung field (black arrow). (b)
Chest CT image showed well-defined mass in right lower lobe (white arrow). There was no remarkable image finding was noted in the
surrounding lung parenchyma.
Figure 2 Postoperative gross examination of lesion.O n
macroscopical examination, the lesion was gray-red solitary nodular
mass without gross necrosis, haemorrhage and calcification,
measuring 2.7 × 2.5 cm, was located in the lung parechyma. The
mass was well-circumscribed, but there was no fibrous capsule
round the mass.
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staining. Based on above findings, a final histological diag-
nosis of PSH combined with primary adenocarcinoma was
made. After surgery, 6 months follow-up was performed
without further treatment. There was no evidence of tumor
recurrence during the period of postoperative follow-up.
The term of “pulmonary sclerosing hemangioma
(PSH)” was first used in 1956 by Liebow and Hubbell, in
which sclerosing hemangioma was described as a variant
of hemangioma due to prominent angiomatoid features
and occurred predominantly in young or middle-aged
women [1]. In 1981, WHO classification of lung tumors
accepted PSH as a tumor-like lesion [4]. However, the
histogenesis of PSH has not yet been elucidated since it
first description. Subsequent studies have postulated
that PSH might originate from mesothelium [5],
mesenchyma [6], epithelium [7], and neuroendocrine
cells [8]. Recent immunohistochemical studies revealed
that PSH might derive from primitive undifferentiated
respiratory epithelium [9,10], and molecular study has
also demonstrated the same monoclonal pattern in both
the round and surface cells, consistent with a ture
Figure 3 Postoperative photomicrographs of lesion in PSH portion. (a) the tumor was composed of sheets of round cells with scattered
surface cuboidal cells forming small tubules. (b) The surface cuboidal cells demonstrated vacuolated and foamy cytoplasm with focal mild
nuclear atypia (black arrow). The round cells showed uniform, medium-size polygonal nuclei with moderate amounts of pale, eosinophilic or
clear cytoplasm (black arrowhead). (c) In some area, papillary pattern with hyalinizing stalks could be obsreved. Both surface cuboidal cells and
round cells could be found in this structure. (d) Immunohistochemically, positivity of surface cuboidal cells, but negativity of round cells for
pancytokeratin was found in tumor. (e) Both surface (black arrow) and round cells (black arrowhead) showed strongly positive for TTF-1. (f) A
focal weak positivity of round cells (black arrowhead) for synaptophysin was observed in this portion, but the surface cells (black arrow) showed
negative for Syn. (a, H&E staining with original magnification of 200 ×; b-c, H&E staining with original magnification of 400 ×; d-f,
immunohistochemical staining with original magnification of 400 ×).
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PSH was categorized as a miscellaneous tumor of lung
in 1999 and 2004 WHO classification of lung tumors
[2,12].
In the current study, we found that both surface and
round cells in PSH portion of mass were immuno-positive
f o rT T F - 1a n dE M A ,b u tr o u n dc e l l sw e r en e g a t i v ef o r
pancytokeratin. These resultsp r o v i d e du s e f u lc l u e sn o t
only for histogenesis but also for the diagnosis of this
tumor. However, in contrast to most previous studies, the
focal weak positivity of round cells, but not surface cells,
for neuroendocrine marker, synaptophysin (Syn) was
found in our case. This result indicated that tumor cells in
PSH, in particular round cells, might have potential to
neuroendocrine differentiation or represent incompletely
differentiated Clara cells. It is well known that TTF-1
expressed in the non-ciliated columnar cells of the fetal
lung as early as 11 weeks of gestation, and in type II pneu-
mocytes and Clara cells of the adult lung [13,14], and both
surface cells and round cells of PSH represented a variable
differentiation from a common progenitor cell [11]. In the
present case, the immunohistochemical positivity of round
cells for TTF-1 and Syn supported that these cells were
derived from a primitive respiratory cell, and part
of round cells might be intermediate differentiation
between undifferentiated primitive respiratory cell and
Figure 4 Postoperative photomicrographs of lesion in adenocarcinoma portion. (a) The tumor cells formed irregular-shaped glands with
infiltrating in the fibroblastic stroma and no gradual transition between adenocarcinoma and PSH was observed. (b) The tumor cells exhibited
cytologically hyperchromatic nuclei, obvious nucleoli and mitotic figures (white arrow). There was no round cells found to distributed in the
interstitial portion of gland structures. Immunohistochemically, tumor cells were positive for pancytokeratin (c), TTF-1 (d) and CEA (e). There was
no TTF-1-positive round cell observed in this portion of mass (a, H&E staining with original magnification of 200 ×; b, H&E staining with original
magnification of 400 ×; c-d, immunohistochemical staining with original magnification of 200 ×; e, immunohistochemical staining with original
magnification of 400 ×).
Liu et al. Diagnostic Pathology 2011, 6:41
http://www.diagnosticpathology.org/content/6/1/41
Page 4 of 6differentiated Clara cells or pneumocytes [9,10]. That
might be the reason why typical carcinoid could be gener-
ated from PSH [15]. Of course, larger series should be
performed to verify this postulation.
PSH is a distinctive lung tumor, which is composed of
mixtures of papillary, solid, sclerotic, and/or hemorrha-
gic patterns with varying proportions of two cell types.
Variable degrees of cytologic atypia were found in most
PSH. The cases of atypical alveolar hyperplasia (AAH)
in PSH [16], alveolar adenoma with PSH [17], and tran-
sition from atypical hyperplasia of type II pneumocyte
to PSH [18] have been described in literatures. Recently,
ac a s eo fa l v e o l a ra d e n o m a - l i k ea r e ai nt h ep e r i p h e r a l
portion of the PSH, and a case of papillary adenocarci-
noma-like area within the PSH have also been reported
[3]. These findings suggested that AAH of type II pneu-
mocytes could be a focus of atypical growth of lining
epithelial cells of PSH, or AAH- and adenocarcinoma-
like lesion with papillae might be presumptive precursor
lesion of PSH. However, in contrast to previous studies,
in our case we found acinar adenocarcinoma coexisted
with PSH in the same nodular mass. We wondered if
this adenocarcinoma portion of mass was a substantive
primary tumor or just a subordinate adenocarcinoma-
like area within the PSH. We reviewed the histological
and immunohistochemical features of unusual presenta-
tions within the PSH in securable literatures. We found
that (a) a gradual transition from unusual structures,
including AAH, avleolar adenoma-like area and adeno-
carcinoma-like area, to the majority of PSH could be
observed in all reported cases; (b) TTF-1 positive round
cells could be detected in varied amount in the intersti-
tial portion of unusual structures. However, in the pre-
sent case, adenocarcinoma portion and PSH portion
were separated distribution without gradual transition
area under the microscopical examination by serial sec-
tion, and there was no TTF-1 positive round cells found
i nt h ef i b r o b l a s t i cs t r o m ao fa d e n o c a r c i n o m a .B a s e do n
those findings, we considered the adenocarcinoma por-
tion was a true primary tumor rather than an unusual
histological presentation of PSH. Existence of adenocar-
cinoma and PSH in different segmental nodular mass of
pulmonary lobe has been described [19]. But to our
knowledge, ours is the first case to demonstrate the
coexistence of adenocarcinoma and PSH within the
same nodule of lung.
PSH is a clinically benign tumor and has a good prog-
nosis after surgical resection. However, lymph node
metastasis and multifocal distribution of PSH have been
found in a few cases [3,15,16,20,21]. Moreover, moder-
ate to severe cytological atypia, and sometimes com-
bined with unusual structures, might make PSH like a
malignancy. The main histological differential diagnosis
includes papillary alveolar adenoma, bronchioloalveolar
carcinoma, carcinoid, and papillary adenocarcinoma, all
of which exhibit papillary, solid or tubular appearance
and may sometimes cause diagnostic confusion with
PSH, especially in insufficient biopsy specimen. How-
ever, the papillary-like structure in PSH is not true
papillae, which is composed of lining cuboidal cells and
round cells below rather than fibrovascular cores pre-
sent in other tumors with true papillary structure. The
presence of pale round cells in tumor and immuno-
positivity of round cells for TTF-1, EMA and ER, PR
support the diagnosis of PSH. There are histological
similarities between carcinoid and PSH when PSH dis-
plays solid histological pattern predominantly, in which
uniform round cells are arranged in sheets pattern. But
lack of strong diffuse TTF-1 reactivity may also be use-
ful in excluding carcinoid. Together with histological
features, immunohistochemical evaluation with a panel
of EMA, pancytokeratin and TTF-1 is most useful in
distinguishing PSH from other similar tumors.
Conclusion
We herein first reported a rare case of PSH combined
with primary adenocarcinoma occurred in the same nod-
ular mass of lung. The mass contained two separated
portions and displayed typically histological features of
PSH and adenocarcinoma, respectively. The precise
mechanism of coexistence of PSH and adenocarcinoma
in the same nodule remains unknown, and longer period
of follow-up and more case investigation are necessary to
better clarify the biological characteristics and clinical
outcomes of this unusual tumor.
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